These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26306727)

  • 1. Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users.
    Ndombi EM; Budambula V; Webale MK; Musumba FO; Wesongah JO; Mibei E; Ahmed AA; Lihana R; Were T
    Endocr Connect; 2015 Dec; 4(4):223-32. PubMed ID: 26306727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya.
    Webale MK; Budambula V; Lihana R; Musumba FO; Nyamache AK; Budambula NL; Ahmed AA; Ouma C; Were T
    BMC Infect Dis; 2015 Jul; 15():299. PubMed ID: 26223795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical chemistry profiles in injection heroin users from Coastal Region, Kenya.
    Were T; Wesongah JO; Munde E; Ouma C; Kahiga TM; Ongecha-Owuor F; Kiarie JN; Ahmed AA; Makokha EP; Budambula V
    BMC Clin Pathol; 2014; 14():32. PubMed ID: 25057262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users.
    Budambula V; Musumba FO; Webale MK; Kahiga TM; Ongecha-Owuor F; Kiarie JN; Sowayi GA; Ahmed AA; Ouma C; Were T
    AIDS Res Ther; 2015; 12():27. PubMed ID: 26279669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China.
    Liu X; He N; Fu Z; Duan S; Gao M; Zhang ZF
    Hepat Mon; 2012 Jul; 12(7):453-9. PubMed ID: 23008726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Infection Burden of Hepatitis C Virus and Human Immunodeficiency Virus among Injecting Heroin Users at the Kenyan Coast.
    Mwatelah RS; Lwembe RM; Osman S; Ogutu BR; Aman R; Kitawi RC; Wangai LN; Oloo FA; Kokwaro GO; Ochieng W
    PLoS One; 2015; 10(7):e0132287. PubMed ID: 26208212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Haplotypes in the
    Nathan S; Valentine B; Tom W
    Ethiop J Health Sci; 2020 Jul; 30(4):489-500. PubMed ID: 33897209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally occurring antiviral drug resistance in HIV patients who are mono-infected or co-infected with HBV or HCV in China.
    Deng H; Deng X; Liu Y; Xu Y; Lan Y; Gao M; Xu M; Gao H; Wu X; Liao B; Chen W; Zhao M; Hu F; Wang Z
    J Med Virol; 2018 Jul; 90(7):1246-1256. PubMed ID: 29574921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive Trajectories After 72 Weeks of First-Line Anti-retroviral Therapy in Vietnamese Adults With HIV-HCV Co-infection.
    Paul RH; Shikuma CM; Chau NVV; Ndhlovu LC; Thanh NT; Belden AC; Chow DC; Chew GM; Premeaux TA; Ly VT; McBride JAD; Bolzenius JD; Le T
    Front Neurol; 2021; 12():602263. PubMed ID: 33776879
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B and hepatitis C virus infections among antiretroviral-naive and -experienced HIV co-infected adults.
    Manyazewal T; Sisay Z; Biadgilign S; Abegaz WE
    J Med Microbiol; 2014 May; 63(Pt 5):742-747. PubMed ID: 24757219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users.
    Oprea C; Ianache I; Radoi R; Erscoiu S; Tardei G; Nicolaescu O; Nica M; Calistru P; Ruta S; Ceausu E
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19625. PubMed ID: 25394129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring hepatitis C virus protease inhibitors resistance-associated mutations among chronic hepatitis C genotype 1b patients with or without HIV co-infection.
    Cao Y; Zhang Y; Bao Y; Zhang R; Zhang X; Xia W; Wu H; Xu X
    Hepatol Res; 2016 May; 46(6):552-8. PubMed ID: 26355704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
    Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
    J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socio-demographic and sexual practices associated with HIV infection in Kenyan injection and non-injection drug users.
    Budambula V; Matoka C; Ouma J; Ahmed AA; Otieno MF; Were T
    BMC Public Health; 2018 Jan; 18(1):193. PubMed ID: 29378631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.